Cancer risk in users of calcium channel blockers

Hypertension

Volumn 29, Issue 5, 1997, Pages 1091-1094

  Olsen, Jørgen H ^a   Sørensen, Henrik Toft ^d   Friis, Søren ^a   McLaughlin, Joseph K ^b   Steffensen, Flemming Hald ^d   Nielsen, Gunnar Lauge ^d   Andersen, Morten ^d   Fraumeni Jr , Joseph F ^c   Olsen, Jørn ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NONE

Author keywords

apoptosis; calcium channel blockers; cohort studies; epidemiology; neoplasms

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; APOPTOSIS; ARTICLE; CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLON CANCER; DENMARK; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030965135     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.5.1091     Document Type: Article

References (28)

1. Horton R. Do calcium antagonists cause cancer? Lancet. 1996; 348:49.
2. Pahor M, Guralnik JM, Salive ME, Corti M-C, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens. 1996;9:695-699.
3. Pahor M, Guralnik JM, Ferrucci L, Corti M-C, Salive ME, Cerhan JR, Wallace RB, Havlik RJ. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 1996;348:493-497.
4. Hardell L, Axelson O, Fredrikson M. Antihypertensive drugs and risk of malignant diseases. Lancet. 1996;348:542.
5. Durham ACH, Walton JM. Calcium ions and the control of proliferation in normal and cancer cells. Biosci Rep. 1982;2:15-30.
6. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 1995;9:219-228.
7. Martin SJ, Green DR. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol. 1995;18: 137-153.
8. Fredrikson M, Hardell L, Bcngtsson NO, Axelson O. Colon cancer and dietary habits, a case-control study. Int J Oncol. 1995;7:133-141.
9. Lipkin M. Supplementary dietary calcium and inhibition of colon cancer. Eur J Cancer Prev. 1993;2:83-84.
10. Cornoni-Huntley J, Ostfeld AM, Taylor JO, Wallace RB, Blazer D, Berkman LF, Evans DA, Kohout FJ, Lemke JH, Scherr PA, Korper SP. Established populations for epidemiologic studies of elderly: study design and methodology. Aging Clin Exp Res. 1993;5:27-37.
11. Merlo J, Ranstam J, Liedholm H, Hedblad B, Lindberg G, Lindblad U, Isacsson S-O, Melander A, Råstam L. Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. Br Med J. 1996;313: 457-461.
12. Wagenknecht LE, Furberg CD, Hammon JW, Legault C. Troost BT. Surgical bleeding: unexpected effect of a calcium antagonist. Br Med J. 1995:310:776-777.
13. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet. 1996;347:1061-1065.
14. Crowson AN, Magro CM. Diltiazem and subacute cutaneous lupus erythematosus-like lesions. N Engl J Med. 1995;333:1429.
15. Pahor M, Guralnik JM, Corti M-C, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc. 1995;43:1191-1197.
16. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
17. Nielsen GL, Sørensen HT, Zhou W, Steffensen FH, Olsen J. The Pharmaco-Epidemiologic Prescription Database of North Jutland. Int J Risk Safety Med. In press.
18. Capellá D. Descriptive tools and analysis. In: Dukes MNG, ed. Drug Utilization Studies: Methods and Uses. Copenhagen, Denmark: WHO Regional Publications; 1993:55-78. European Series No. 45.
19. Sørensen HT, Larsen BO. A population-based Danish data resource with possible high validity in pharmaco-epidemiological research. J Med Syst. 1994;18:33-38.
20. Jensen OM, Storm HH, Jensen HS. Cancer registration in Denmark and the study of multiple primary cancers, 1943-1980. Natl Cancer Inst Monogr. 1985;68:245-251.
21. Storm HH, Phil J, Michelsen E. Cancer Incidence in Denmark, 1993. Copenhagen, Denmark: Danish Cancer Society: 1996.
22. Østerlind A. Non-melanoma skin cancer in Denmark 1943-1982. Ugeskr Laeg. 1986;148:798-802.
23. Rothman KJ, Boice JD Jr. Epidemiologic Analysis With a Programmable Calculator. Washington, DC: Government Printing Office: 1979. Dept of Health and Human Services publication (NIH) 79-1649.
24. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Poul L. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985;1: 307-309.
25. Hardell L, Fredrikson M, Axelson O. Case-control study of colon cancer regarding previous diseases and drug intake. Int J Oncol. 1996;8:439-444.
26. Svadicani P, Hein HO, Gyntelberg F. Is use of antihypertensives and sedatives a major risk factor for colorectal cancer? Scand J Gastroenterol. 1993;28:475-481.
27. Nielsen GL, Sørensen HT, Pedersen AB, Sabroe S. Analyses of data quality in registries concerning diabetes mellitus: a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst. 1996;20:1-10.
28. Olsen JH, Boice JD Jr, Seersholm N, Bautz A, Fraumeni JF Jr. Cancer in the parents of children with cancer. N Engl J Med. 1995;333:1594-1599.